These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4923003)

  • 1. Weight changes with schizophrenic psychosis and psychotropic drug therapy.
    Holden JM; Holden UP
    Psychosomatics; 1970; 11(6):551-61. PubMed ID: 4923003
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory changes with chlordiazepoxide and thioridazine, alone and combined.
    Holden JM; Itil TM
    Can Psychiatr Assoc J; 1969 Jun; 14(3):299-301. PubMed ID: 4890979
    [No Abstract]   [Full Text] [Related]  

  • 3. Itil TM, Keskiner A, Fink M: Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia.
    Holden JM
    Compr Psychiatry; 1968 Nov; 9(6):633-43. PubMed ID: 4883430
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study.
    Sterlin C; Augustin E; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):50-2. PubMed ID: 4992566
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 6. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.
    Hekimian LJ; Friedhoff AJ
    Dis Nerv Syst; 1967 Oct; 28(10):675-8. PubMed ID: 4860896
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined drug treatment of newly hospitalized, acutely ill psychiatric patients.
    Hanlon TE; Ota KY; Agallianos DD; Berman SA; Bethon GD; Kobler F; Kurland AA
    Dis Nerv Syst; 1969 Feb; 30(2):104-16. PubMed ID: 4388249
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine.
    Hanlon TE; Ota KY; Kurland AA
    Dis Nerv Syst; 1970 Mar; 31(3):171-7. PubMed ID: 4909632
    [No Abstract]   [Full Text] [Related]  

  • 11. [The risk of heart disease in various psychiatric diseases].
    Schwalb H; van Eimeren W; Friedrich HV
    Z Kardiol; 1976 Dec; 65(12):1115-23. PubMed ID: 1014803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
    Luckey WT; Schiele BC
    Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
    [No Abstract]   [Full Text] [Related]  

  • 13. Weight as a correlate of clinical response to psychotropic drugs.
    Singh MM; De Dios LV; Kline NS
    Psychosomatics; 1970; 11(6):562-70. PubMed ID: 4923004
    [No Abstract]   [Full Text] [Related]  

  • 14. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatment of schizophrenic psychoses with neuroleptics combined with subcomatic insulin].
    Majewski J; Stempurska K
    Psychiatr Pol; 1968; 2(1):37-42. PubMed ID: 4875961
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlordiazepoxide in the treatment of patients with "activated EEG's".
    Monroe RR; Dale R
    Dis Nerv Syst; 1967 Jun; 28(6):390-6. PubMed ID: 5340423
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychiatric status and the disorders of thyroid function. I. Prevalence of goitre in a group of psychiatric patients. I. The prevalence of goitre in a group of psychiatric patients.
    Rwegellara GG; Mambwe CC
    Med J Zambia; 1977; 11(3):78-83. PubMed ID: 899293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study.
    Kellner R; Wilson RM; Muldawer MD; Pathak D
    Arch Gen Psychiatry; 1975 Oct; 32(10):1246-54. PubMed ID: 241306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydroxyzine on phenothiazine therapy.
    Ross EK; Priest RG
    Dis Nerv Syst; 1970 Jun; 31(6):412-4. PubMed ID: 4393988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.